Identification of Serum CMTM2 as a Potential Biomarker for HBV-Related Disorders

Figure 8

Differentiating power of CMTM2 for progression of HBV-related disorders. Receiver operating characteristic (ROC) curve of CMTM2 for detecting CHB patients from HCs (a). ROC curve of CMTM2 for detecting HBLC patients from HCs (b). ROC curve of CMTM2 for detecting HCC patients from HCs (c). ROC curve of CMTM2 for detecting HBLC and HCC patients from CHB (d).

(a)

(b)

(c)

(d)